The stock of TESARO Inc (NASDAQ:TSRO) reached all time high today, Oct, 28 and still has $149.24 target or 22.00% above today’s $122.33 share price. This indicates more upside for the $6.24 billion company. This technical setup was reported by Barchart.com. If the $149.24 PT is reached, the company will be worth $1.37B more.
Trading stocks at an all time highs is usually a winning strategy. An all time high points to a stock which has the most positive fundamentals ever. Even thought the pullback rate is high, if correct risk management is utilized, investors can trade very well such events. About 477,424 shares traded hands. TESARO Inc (NASDAQ:TSRO) has risen 157.07% since March 28, 2016 and is uptrending. It has outperformed by 152.36% the S&P500.
Analysts await TESARO Inc (NASDAQ:TSRO) to report earnings on November, 3. They expect $-1.92 EPS, down 15.66% or $0.26 from last year’s $-1.66 per share. After $-1.28 actual EPS reported by TESARO Inc for the previous quarter, Wall Street now forecasts 50.00% negative EPS growth.
TESARO Inc (NASDAQ:TSRO) Ratings Coverage
Out of 12 analysts covering Tesaro Inc (NASDAQ:TSRO), 11 rate it a “Buy”, 1 “Sell”, while 0 “Hold”. This means 92% are positive. Tesaro Inc has been the topic of 20 analyst reports since August 24, 2015 according to StockzIntelligence Inc. Wedbush maintained it with “Outperform” rating and $107 target price in Friday, August 5 report. The stock of TESARO Inc (NASDAQ:TSRO) earned “Neutral” rating by Bank of America on Tuesday, August 30. The stock of TESARO Inc (NASDAQ:TSRO) has “Outperform” rating given on Monday, October 10 by Wedbush. The stock of TESARO Inc (NASDAQ:TSRO) has “Buy” rating given on Friday, February 5 by Lake Street. The company was initiated on Thursday, January 21 by Wedbush. The firm has “Strong-Buy” rating given on Tuesday, September 1 by Raymond James. RBC Capital Markets initiated the shares of TSRO in a report on Friday, August 12 with “Outperform” rating. The stock of TESARO Inc (NASDAQ:TSRO) has “Outperform” rating given on Friday, December 4 by Wells Fargo. The firm earned “Outperform” rating on Monday, October 10 by RBC Capital Markets. The stock of TESARO Inc (NASDAQ:TSRO) has “Buy” rating given on Thursday, March 17 by Citigroup.
According to Zacks Investment Research, “Tesaro, Inc. is an oncology-focused biopharmaceutical company for cancer patients. The Company’s product portfolio consists of Rolapitant, a neurokinin-1 receptor antagonist for the prevention of chemotherapy induced nausea and vomiting, TSR-011, an orally available anaplastic lymphoma kinase inhibitor for the treatment of non-small cell lung cancer and other cancer indications, and Niraparib, an orally active and potent poly (ADP-ribose) polymerase inhibitor for the treatment of patients with solid tumors. Tesaro, Inc. is based in Waltham, Massachusetts.”
Insitutional Activity: The institutional sentiment increased to 1.55 in Q2 2016. Its up 0.32, from 1.23 in 2016Q1. The ratio improved, as 24 funds sold all TESARO Inc shares owned while 36 reduced positions. 34 funds bought stakes while 59 increased positions. They now own 44.90 million shares or 3.32% less from 46.44 million shares in 2016Q1.
Great West Life Assurance Company Can last reported 0% of its portfolio in the stock. Fred Alger Mgmt accumulated 103,777 shares or 0.05% of the stock. Whittier accumulated 0.04% or 10,839 shares. Nomura Holding Inc accumulated 0.01% or 28,600 shares. Putnam Investments Limited accumulated 824,240 shares or 0.17% of the stock. Vanguard last reported 0.01% of its portfolio in the stock. Td Asset Mgmt accumulated 0.02% or 113,153 shares. The United Kingdom-based Legal And General Public Limited Company has invested 0% in TESARO Inc (NASDAQ:TSRO). Sei holds 0% of its portfolio in TESARO Inc (NASDAQ:TSRO) for 68 shares. The United Kingdom-based Barclays Pcl has invested 0.01% in TESARO Inc (NASDAQ:TSRO). Passport Ltd Limited Liability Company reported 734,327 shares or 1.13% of all its holdings. Teachers Retirement System Of The State Of Kentucky accumulated 15,135 shares or 0.02% of the stock. Quantitative Systematic Strategies Limited Liability owns 2,946 shares or 0.11% of their US portfolio. Moreover, Hap Trading Ltd has 0.06% invested in TESARO Inc (NASDAQ:TSRO) for 12,310 shares. Highbridge Management Limited Liability Co has 0.06% invested in the company for 42,648 shares.
Insider Transactions: Since June 10, 2016, the stock had 0 buys, and 5 insider sales for $4.39 million net activity. Huber Martin H. Jr. also sold $44,113 worth of TESARO Inc (NASDAQ:TSRO) on Wednesday, September 21. Hanke Jeffrey H. sold $2.51M worth of TESARO Inc (NASDAQ:TSRO) on Tuesday, August 30. 7,000 shares with value of $285,274 were sold by English Edward C on Friday, June 10.
More recent TESARO Inc (NASDAQ:TSRO) news were published by: Fool.com which released: “Tesaro Inc. Is Flying High Today (and Could Go Higher From Here)” on October 10, 2016. Also Investorplace.com published the news titled: “Tesaro Inc (TSRO) Soars on Trial Data, Analyst Upgrades” on October 10, 2016. Investorplace.com‘s news article titled: “Why Alphabet Inc (GOOG), Mylan NV (MYL) And Tesaro Inc (TSRO) Are 3 of Today’s …” with publication date: October 10, 2016 was also an interesting one.
TSRO Company Profile
TESARO, Inc. (TESARO), incorporated on March 26, 2010, is an oncology-focused biopharmaceutical company. The Firm acquires, in-licenses and develops oncology product candidates. The Firm operates in business of developing and commercializing oncology-focused therapeutics segment. The Firm has in-licensed and are developing oncology-related product candidates, including intravenous (IV) rolapitant and niraparib, as well as product candidates under its immuno-oncology platform.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.